From integrative genomics to therapeutic targets.

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Breast cancer research increasingly integrates pathology with genomic and functional genomics.
• Understanding the genetic basis of breast cancer subtypes is crucial for targeted therapy development.

Purpose of the Study:

• To explore how combinatorial approaches enhance the understanding of breast cancer's genetic underpinnings.
• To identify key genotypic-phenotypic correlations and genetic dependencies in breast cancer subtypes.
• To discuss the application of this knowledge in defining novel, tailored therapies for cancer patients.

Main Methods:

• Utilizing combinatorial approaches integrating conventional pathology with genomic and functional genomics.
• Characterizing the mutational repertoire of breast cancers using next-generation sequencing.
• Focusing on homogeneous subgroups and integrating orthogonal data types with functional approaches.

Main Results:

• Identification of key genotypic-phenotypic correlations in various breast cancer subtypes.
• Discovery of specific genetic dependencies driving tumor behavior.
• Application of genomic insights to define novel, tailored therapeutic strategies.

Conclusions:

• Combinatorial approaches are vital for unraveling breast cancer heterogeneity.
• Identifying driver events requires integrating diverse data types and functional studies.
• Targeting specific genetic aberrations offers a path toward more effective breast cancer treatments.